Results 161 to 170 of about 148,724 (217)

Receptor-Selective Modulation of Cannabinoid Signaling by Cardamonin: Integrating Molecular Dynamics, Free Energy Calculations, and Behavioral Validation. [PDF]

open access: yesACS Omega
Khalid MH   +7 more
europepmc   +1 more source

Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models. [PDF]

open access: yesCurr Top Behav Neurosci
Bedillion MF   +5 more
europepmc   +1 more source

Sublingual Administration for Pain Control: Pharmacology, Clinical Applications and Future Directions. [PDF]

open access: yesCNS Drugs
Koushik SS   +9 more
europepmc   +1 more source

Aminopyrazine CB1 Receptor Inverse Agonists

Bioorganic and Medicinal Chemistry Letters, 2008
A series of 5,6-diaryl-2-amino-pyrazines were prepared and found to have antagonist-like properties at the CB1 receptor. Subsequent SAR studies optimized both receptor potency and drug-like properties including solubility and Cytochrome-P450 inhibition potential.
James E Krause, Bertrand L Chenard
exaly   +3 more sources

Lead Optimization of 5,6-Diarylpyridines as CB1 Receptor Inverse Agonists

Bioorganic and Medicinal Chemistry Letters, 2007
Optimization of the biological activity for 5,6-diarylpyridines as CB1 receptor inverse agonists is described. Food intake and pharmacokinetic evaluation of 3f and 15c indicate that these compounds are effective orally active modulators of CB1.
Lex H T van der Ploeg   +2 more
exaly   +3 more sources

Synthesis and Activity of 4,5-Diarylimidazoles as Human CB1 Receptor Inverse Agonists

Bioorganic and Medicinal Chemistry Letters, 2005
Structure-activity relationship studies directed toward the optimization of 4,5-diarylimidazole-2-carboxamide analogs as human CB1 receptor inverse agonists resulted in the discovery of the two amide derivatives 24a and b (hCB1 IC50 = 6.1 and 4.0 nM) which also demonstrated efficacy in overnight feeding studies in the rat for reduction in both food ...
Christopher W Plummer   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy